Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Reportable Diseases topic
No spam. Unsubscribe anytime.
House Health panel advances bill to make alpha-gal syndrome reportable
Summary
The House Health Full Committee voted unanimously to send House Bill 383 to calendar and rules, a measure to add alpha-gal syndrome to the Tennessee Department of Health's list of reportable conditions after testimony on the allergy's prevalence and diagnostic challenges.
The House Health Full Committee voted unanimously to advance House Bill 383 to calendar and rules, approving language to add alpha-gal syndrome to the Tennessee Department of Health's published list of reportable diseases and conditions.
The bill's sponsor, Representative Brett Butler, told the committee that the measure would require health care providers to report occurrences under existing administrative rules and would help state and local officials track the condition. Butler summarized research and local findings cited in committee discussion, including studies suggesting a high level of sensitization in parts of Tennessee and wide uncertainty about actual case counts.
Jody Zorsch of Morgan County, who said she is among those diagnosed with alpha-gal, told the committee she waited about 10 years for a diagnosis and urged lawmakers to support reporting to improve prevalence data and labeling. "Reporting would be helpful because as Representative Butler said, this is a high prevalence food allergy," Zorsch said. She described severe reactions she suffered before receiving a diagnosis and asked lawmakers to act so others would not face the same risk.
Members discussed practical implications: Representative Julie Lynn asked what labeling for products should say; Zorsch suggested labels indicate "mammal products and byproducts." Committee members also noted the clinical implications for hospitals and the possibility of environmental interventions; Chairman White referenced a Memphis company, US Biologic, that has worked on field products intended to interrupt tick-borne cycles.
Butler and other members cited Centers for Disease Control and Prevention guidance urging state and local health authorities to begin surveillance for alpha-gal. Committee discussion referenced research estimates presented in the hearing record, including a military-recruit study suggesting about 10 percent sensitization in some samples and an illustrative estimate that 0.5 to 1 percent of the Tennessee population might have alpha-gal syndrome (quoted in committee as roughly "35,000 to 70,000" people), while acknowledging the true prevalence is not well established because surveillance is limited.
After about three minutes of testimony and questions, the committee voted 23-0 to move the bill forward.
The bill now proceeds to calendar and rules for further consideration.
